Management of psychosocial distress by oncologists.

Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115, USA.
Psychiatric services (Washington, D.C.) (Impact Factor: 2.81). 09/2009; 60(8):1132-4. DOI: 10.1176/
Source: PubMed

ABSTRACT Little is known about the nature of psychosocial care delivered by oncologists. The goal of this study was to survey oncologists about their management of psychosocial distress, referencing the National Comprehensive Cancer Network guidelines.
A random sample of 1,000 oncologists were sent an e-mail requesting their participation in an online survey; nonrespondents were sent the survey through postal mail. Regression analyses were conducted to identify independent predictors of care.
Forty-six percent (448 of 965) of oncologists responded. Practice locations included: community (63%), cancer center (25%), and hospital (7%). Respondents estimated that over one-third of their patients (mean+/-SD=38%+/-22%) experience psychosocial distress warranting intervention, although only 225 of 447 (50%) indicated having mental health services affiliated with their practice. Nearly half (212 of 447, 47%) reported only initiating a referral for psychosocial services, and 214 of 447 (48%) reported both making a referral and starting psychiatric medications, mainly selective serotonin reuptake inhibitors and benzodiazepines.
Most oncologists delivered some level of psychosocial care, although only half had affiliated mental health services.

  • Source
    03/2014; 7(1): 41-56. DOI:10.1179/1753807614Y.0000000047
  • Journal of Clinical Oncology 04/2013; DOI:10.1200/JCO.2012.48.0566 · 17.88 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Distress is a psychological state that is often observed in patients with chronic disease. Many cancers are considered chronic in nature, with patients experiencing long, disease-free states and intervals of metastatic disease. Distress can negatively affect the biopsychosocial balance in cancer survivors and impede their progress along the cancer trajectory. Distress can also affect medical and psychological outcomes and hinder advancement into long-term survivorship. Distress may contribute to disease progression, although despite research findings, health-care providers seldom screen for indications of persistent or unresolved distress. This article discusses research findings related to the prevalence of distress in multiple chronic diseases. Validated instruments used to screen for distress in cancer survivors, such as the Distress Thermometer and symptom checklist from the National Comprehensive Cancer Network, are reviewed. With the availability of brief and concise instruments to screen for distress, providers have the ability to provide holistic and comprehensive care for cancer survivors. The overall financial impact of cancer-related distress is understudied, although similar psychological studies indicate that prevention or elimination of distress is beneficial. Cancer is a lifelong, chronic disease; patients have ongoing needs and varied sources of distress. As the number of cancer survivors exponentially increases, their psychosocial needs will likewise expand.
    03/2014; 5(2):107-14.
    This article is viewable in ResearchGate's enriched format

Full-text (2 Sources)

Available from
May 22, 2014